BPC-157 and NAD+
BPC-157 + Nicotinamide Adenine Dinucleotide Protocol
Overview
The BPC-157 and NAD+ combination has emerged as one of the most discussed gut health and systemic repair protocols in the peptide research community. BPC-157 provides targeted gastrointestinal healing and tissue repair while NAD+ supports cellular energy production and DNA repair through sirtuin activation. Together they address both the structural repair of damaged tissue and the cellular energy infrastructure required for optimal healing. This combination is particularly popular for gut health recovery inflammatory bowel conditions and systemic anti-aging protocols.
Mechanism of Action
BPC-157 promotes gastric mucosal healing through upregulation of growth hormone receptors and VEGF-driven angiogenesis stabilizing the nitric oxide system and reducing inflammatory cytokine production in gastrointestinal tissue. NAD+ replenishes cellular coenzyme levels supporting mitochondrial energy production PARP-mediated DNA repair and sirtuin deacetylase activity. The combination addresses healing at two levels — BPC-157 repairs the structural tissue damage while NAD+ restores the cellular metabolic capacity required for efficient repair. NAD+ supplementation also supports the energy-intensive process of tissue regeneration that BPC-157 initiates making the combination theoretically synergistic for recovery applications.
Dosage Information
Typical Dose
BPC-157: 250-500 mcg + NAD+: 250-500 mg
Frequency
BPC-157 once or twice daily. NAD+ once daily in the morning.
Administration
BPC-157 subcutaneous injection. NAD+ oral capsule or IV infusion.
Notes
BPC-157 oral form (arginate) can be used for gastrointestinal applications. IV NAD+ provides faster cellular uptake but oral NMN or NR are more practical for daily use as NAD+ precursors.
Where does BPC-157 and NAD+ sit?
See how this peptide compares across all 111 peptides in our database.
Evidence Score
0.07
Potential Side Effects
Community Experiences
No experiences shared yet. Be the first!
Quick Facts
- Administration
- BPC-157 subcutaneous injection. NAD+ oral capsule or IV infusion.
- Typical Dose
- BPC-157: 250-500 mcg + NAD+: 250-500 mg
- Frequency
- BPC-157 once or twice daily. NAD+ once daily in the morning.
- References
- 0 curated + 0 from PubMed
- Evidence Score
- 0.1 / 100